Key result
Elevated remnant cholesterol is not independently associated with high HbA1c in new CHD patients.
Why the study?
The relationship between HbA1c and lipid profiles remained unclear in patients newly diagnosed with CHD at very high ASCVD risk.
Cross-Sectional (n=731)
No
Answers are grounded in this paper and cite their sources.
In very high-risk ASCVD patients with newly diagnosed CHD, baseline LDL-C levels consistently exceeded guideline targets (>100 mg/dL across all HbA1c strata), and unadjusted associations between elevated HbA1c (>=6.5%) and elevated remnant cholesterol or triglycerides were no longer statistically significant after accounting for prior type 2 diabetes history.
Background The relationship between HbA1c and lipid profiles remains unclear in patients newly diagnosed with coronary heart disease (CHD) at very high ASCVD risk. This study investigated this association. Methods A total of 731 such patients were recruited and categorized by HbA1c: ≥6.5%, 5.7%–6.4%, and <5.7%. Lipid profiles were compared. Results Compared with HbA1c < 5.7%, the ≥6.5% group had a higher prevalence of hypertension and diabetes and was older ( P < 0.05). In unadjusted analyses, total cholesterol (182.6 ± 52.4 vs. 170.1 ± 38.7 mg/dL) and triglycerides (median 143.4 [106.6–219.9] vs. 115.9 [89.4–161.1] mg/dL) were higher in the ≥6.5% group ( P < 0.05). LDL-C and HDL-C did not differ significantly, but mean LDL-C exceeded 100 mg/dL in all groups, above the guideline-recommended threshold for very-high-risk patients. Non-HDL-C was higher in the ≥6.5% group than in the <5.7% group but not the 5.7%–6.4% group. RC was higher in the ≥6.5% group than in the 5.7%–6.4% group but not the <5.7% group. TG ≥ 150 mg/dL was more prevalent in the ≥6.5% group than in both lower groups; TC ≥ 200 mg/dL differed only versus the <5.7% group, and RC ≥ 19 mg/dL only versus the 5.7%–6.4% group. After adjustment for sex, age, BMI, smoking, hypertension, and T2DM history, neither RC ≥ 19 mg/dL (aOR=1.506, 95% CI:0.888–2.553, P = 0.129) nor TG ≥ 150 mg/dL (aOR=1.212, 95% CI:0.765–1.919, P = 0.414) remained significant. In a secondary model without T2DM adjustment, RC ≥ 19 mg/dL was associated with HbA1c ≥ 6.5% (aOR=1.650, 95% CI:1.085–2.510, P = 0.019), whereas TG ≥ 150 mg/dL was not (aOR=1.376, 95% CI:0.961–1.971, P = 0.082). Conclusion In very high-risk ASCVD patients with newly diagnosed CHD, LDL-C at diagnosis exceeded guideline-recommended targets. After adjustment for T2DM history, neither RC nor TG remained significantly associated with HbA1c ≥ 6.5%. The RC association was attenuated after accounting for T2DM history, suggesting it is not robust to diabetes status. Future longitudinal studies are needed to clarify whether HbA1c provides additional information beyond T2DM status.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cross-sectional in Newly diagnosed coronary heart disease at very high-risk ASCVD (n=731). Remnant cholesterol (RC) ≥19 mg/dL vs. Remnant cholesterol (RC) <19 mg/dL was evaluated on Elevated HbA1c (≥6.5%) (OR 1.506, 95% CI 0.888-2.553, p=0.129). Remnant cholesterol ≥/dL was not associated with HbA1c ≥6.5% after adjusting for type 2 diabetes history in newly diagnosed CHD patients.
Synapse has enriched 10 related papers. Consider them for comparative context: